Looks like this company has big potential to move up once it announces phase III study.
Sentiment: Strong Buy
They've got grants, and the government is bankrolling them with 100 million.
Study Start Date: August 2013 ?
"Tetraphase is planning to advance eravacycline into Phase 3 clinical studies in cIAI and cUTI in the second half of this year. "
Read through the pdf from a recent presentation which seemed to indicate that its already in phase III. if you find any clarification on this, please post.